Ergoteles’s Medifast MED Stock Holding History

Ergoteles’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6,839	Closed	-$630K	–	524
2023 Q2	$630K	Buy	+6,839	New	+$609K	0.03%	590
2023 Q1	–	Sell	-2,045	Closed	-$236K	–	1557
2022 Q4	$236K	Sell	2,045 -3,446	-63%	-$401K	0.01%	1006
2022 Q3	$595K	Buy	5,491 +3,157	+135%	+$452K	0.02%	690
2022 Q2	$421K	Buy	+2,334	New	+$418K	0.01%	915

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ergoteles's MED Position: Q3 2023 in Review

Ergoteles sold out of Medifast (MED) in Q3 2023, closing a stake of 6,839 shares — an estimated $630K sold.

Ergoteles first reported a position in MED in Q2 2022 and held it in 4 quarters. The position peaked at $630K in Q2 2023. 223 funds tracked by Wall St. Rank hold MED as of Q3 2023.

Ergoteles reported no remaining Medifast position as of Q3 2023 after selling out during the quarter.
Ergoteles sold 6,839 Medifast shares in Q3 2023, an estimated $630K.
Ergoteles first reported a position in Medifast in Q2 2022 and held it in 4 quarters.
Ergoteles's Medifast position peaked at $630K in Q2 2023.
223 funds tracked by Wall St. Rank held Medifast as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.